Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Lineage Cell Therapeutics Ord Shs (LCTX)  
$0.92 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 149,990,000
Market Cap: 137.98(M)
Last Volume: 394,168 Avg Vol: 180,345
52 Week Range: $0.9199 - $0.9199
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 10,000 6,846,925 6,846,925 6,846,925
Total Buy Value $10,500 $7,121,402 $7,121,402 $7,121,402
Total People Bought 1 4 4 4
Total Buy Transactions 1 5 5 5
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-01 2023-11-29 2023-05-31 2022-05-31

   
Records found: 413
  Page 17 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Greenway Partners L P 13D Group-10% Owner   –       –      –    2004-01-21 4/A OE $1.40 $124,950 D/D 89,250 180,000     -
   Kingsley Alfred D 13D Group-10% Owner   –       –      –    2004-01-21 4/A OE $1.40 $547,567 D/D 391,119 2,279,828     -
   Kingsley Alfred D 13D Group-10% Owner   –       –      –    2004-01-21 4/A OE $1.40 $544,662 D/D 389,044 2,277,753     -
   Nickel Jeffrey B Director   –       •      –    2004-01-21 4/A OE $1.40 $2,625 D/D 1,875 11,875     -
   Nickel Jeffrey B Director   –       •      –    2004-01-21 4 OE $1.40 $1,750 D/D 1,250 11,250     -
   Segall Judith VP;Member, Office of President   •       •      –    2004-01-21 4 OE $1.40 $60,444 D/D 43,174 388,582     -
   Duberstein Gary K 13D Group-10% Owner   –       –      –    2004-01-21 4 OE $1.40 $1,905 D/D 1,361 12,256     -
   Greenbelt Corp /ny 13D Group-10% Owner   –       –      –    2004-01-21 4 OE $1.40 $135,530 D/D 96,807 951,267     -
   Waitz Harold D VP;Member, Office of President   •       •      –    2004-01-21 4 OE $1.40 $21,727 D/D 15,519 139,685     -
   Sternberg Hal VP;Member, Office of President   •       •      –    2004-01-21 4 OE $1.40 $37,608 D/D 26,863 241,770     -
   Greenbelt Corp /ny 13D Group-10% Owner   –       –      –    2003-10-08 4 A $0.00 $0 D/D 80,000 814,460     -
   Kingsley Alfred D 13D Group-10% Owner   –       –      –    2003-10-08 4 A $0.00 $0 I/I 80,000 814,460     -
   Duberstein Gary K 13D Group-10% Owner   –       –      –    2003-10-08 4 A $0.00 $0 I/I 80,000 814,460     -

  413 Records found
  Previous  10  11  12  13  14  15  16  17    
  Page 17 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed